Table 4.
SENSITIVITY | SPECIFICITY | |||||||
---|---|---|---|---|---|---|---|---|
Urine high-risk HPV | Cervical high-risk HPV | Urine high-risk HPV | Cervical high-risk HPV | |||||
Clinical endpoint | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI |
Cervical HPV (n=51) | 51.0 | 37.0 - 65.0 | N/A | 96.2 | 92.0 - 99.0 | N/A | ||
ASCUS/LSIL/HSIL (n=38) | 47.4 | 31.0 - 64.2 | 57.9 | 40.8 - 73.7 | 92.0 | 86.9 - 95.5 | 83.5 | 77.2 - 88.7 |
HPV – Human papilloma virus, CI=– confidence interval, ASCUS – atypical squamous cells of undetermined significance, LSIL – low-grade squamous intraepithelial Lesion, HSIL – high-grade squamous intraepithelial lesion, N/A – not applicable